| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.092 | 0.06 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.058 | 0.06 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.06 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.06 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.056 | 0.07 |